Drug GMP Report
September 2012
Tougher USP Heparin Standard Can’t Beat Beefy Supplier Controls: FDA
While an impending update to the U.S. Pharmacopeia’s (USP) reference standard for heparin sodium will sharpen the drug’s monograph, there is no substitute for solid supplier quality control to prevent contaminants in heparin and other active pharmaceutical ingredients (API), FDA officials say.
This article is viewable by subscribers only. To view this article, please select an option below.
|